4//SEC Filing
Myer Vickesh 4
Accession 0001179110-19-002313
CIK 0001650664other
Filed
Feb 21, 7:00 PM ET
Accepted
Feb 22, 4:11 PM ET
Size
8.8 KB
Accession
0001179110-19-002313
Insider Transaction Report
Form 4
Myer Vickesh
Chief Technology Officer
Transactions
- Sale
Common Stock
2019-02-20$20.42/sh−3,000$61,260→ 0 total - Exercise/Conversion
Stock Option (right to buy)
2019-02-20−3,000→ 76,307 totalExercise: $0.65Exp: 2025-04-29→ Common Stock (3,000 underlying) - Exercise/Conversion
Common Stock
2019-02-20$0.65/sh+3,000$1,950→ 3,000 total
Footnotes (3)
- [F1]The exercise and sale reported on this Form 4 were effected pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on September 15, 2017.
- [F2]This transaction was executed in multiple trades at prices ranging from $20.31 to $20.56. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and the prices at which the transaction was effected.
- [F3]This option was granted on April 30, 2015 and is scheduled to vest over four years, with 25% of the shares having vested on April 21, 2016, and the remaining 75% of the shares scheduled to vest in equal monthly installments thereafter through April 21, 2019.
Documents
Issuer
Editas Medicine, Inc.
CIK 0001650664
Entity typeother
Related Parties
1- filerCIK 0001742806
Filing Metadata
- Form type
- 4
- Filed
- Feb 21, 7:00 PM ET
- Accepted
- Feb 22, 4:11 PM ET
- Size
- 8.8 KB